Product Name | MF | CAS | Details |
---|
A1B11 | C22H25N5O | 1602731-56-5 | Details |
AY 9944 dihydrochloride | C22H28Cl2N2 | 1245-84-7 | Details |
20681-S | C21H29NO5S | 73361-71-4 | Details |
PF-06795071 | C18H17F4N3O3 | 2075629-81-9 | Details |
CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
Oral antiplatelet agent 1 | C23H24N4O5S | 2299200-91-0 | Details |
Galidesivir triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
GLPG-3221 | C30H37F3N2O6 | 2222264-64-2 | Details |
Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
Lesopitron HCl | 132449-88-8 | Details |
Levomecol | C16H18Cl2N4O7 | 118573-58-3 | Details |
UB 165 fumarate | 2454492-43-2 | Details |
LBW242 | C27H42N4O2 | 867324-12-7 | Details |
Phortress free base | C20H23FN4OS | 741241-36-1 | Details |
c-Fms-IN-7 | C26H24N6OS | 1313408-89-7 | Details |
DC4SMe | C35H31ClN5O7PS2 | 615538-47-1 | Details |
QPX7728 bis-acetoxy methyl ester | C15H14BFO8 | 2170834-56-5 | Details |
(S)-BI 665915 | C24H26N8O2 | 1360550-05-5 | Details |
gamma-secretase modulator 1 hydrochloride | C24H25ClN4OS | 2741571-83-3 | Details |
Atiratecan | C31H34N6O6 | 867063-97-6 | Details |
DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
OMDM-3 | C29H43NO3 | 616884-64-1 | Details |
OSMI-3 | C32H35N3O9S2 | 2260791-13-5 | Details |
VDR agonist 1 | C32H51N3O2 | 2269494-43-9 | Details |
A-424274 | C14H15N3 | 1335145-56-6 | Details |
Oxaquin | C31H33F2N4O11P | 790704-50-6 | Details |
PDE1-IN-3 | C18H24N4O | 2370966-46-2 | Details |
IDO1-IN-2 | C15H17FN6O4 | 2346614-58-0 | Details |
NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
PDE5-IN-2 | C25H21N3O6S | 2244517-61-9 | Details |
CP5V | C46H66Cl3N9O12S | 2509359-75-3 | Details |
5-Hydroxylansoprazole sulfone | C16H14F3N3O4S | 131927-00-9 | Details |
JBJ-02-112-05 | C27H20N4O2S | 2748162-29-8 | Details |
Turbinaric acid | C27H44O2 | 56882-00-9 | Details |
7-Deoxyloganic acid | C16H24O9 | 22487-36-1 | Details |
Fobrepodacin disodium | C21H27FN6NaO6P | 1384984-20-6 | Details |
AN11251 | C29H38BFO7 | 2130750-59-1 | Details |
MCL-1/BCL-2-IN-4 | C26H23BrN2O5S | 2163793-56-2 | Details |
Cdc7-IN-3 | C20H22N4O5 | 1402057-87-7 | Details |
BIZ 114 | C24H40O3 | 2099120-74-6 | Details |
D-Cl-amidine | C14H19ClN4O2 | 1404060-15-6 | Details |
Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
Flibanserin-d4 | C20H21F3N4O | 2122830-90-2 | Details |
RORγt Inverse agonist 2 | C27H25F8NO5S | 1801197-92-1 | Details |
Syk-IN-3 | C24H28N4O3S | 1312534-69-2 | Details |
Tyk2-IN-9 | C20H17N9 | 2127109-85-5 | Details |
Murizatoclax | C42H57ClN4O5S | 2245848-05-7 | Details |
SLLN-15 | C19H23N7Se2 | 2403650-93-9 | Details |
Atopaxar hydrochloride | C29H39ClFN3O5 | 474544-83-7 | Details |
Integrin-IN-2 | C27H30N4O3 | 2378617-67-3 | Details |
OMDM-4 | C29H43NO3 | 616884-65-2 | Details |
PKR activator 1 | C16H14N8OS2 | 2283420-62-0 | Details |
RORγt agonist 1 | C24H17F6NO5S | 2377378-89-5 | Details |
TP3011 | C26H26N4O5 | 534605-74-8 | Details |
Ppc-1 | C21H25NO4 | 1245818-17-0 | Details |
Mebeverine alcohol D5 | C16H27NO2 | 2070015-15-3 | Details |
Pulrodemstat Methylbenzenesulfonate | C31H31F2N5O5S | 2097523-57-2 | Details |
PDE9-IN-1 | C17H23FN6O2 | 2305087-92-5 | Details |
BN201 | C25H38FN5O4 | 1361200-34-1 | Details |
(+)-SHIN1 | C24H24N4O2 | 2443966-90-1 | Details |
TLC3407-3786 | C19H19N3O4 | 896356-25-5 | Details |
58-G3 | C14H12Cl2N4O5 | 287174-44-1 | Details |
Alvameline maleate | C13H19N5O4 | 219581-36-9 | Details |
Cdc7-IN-4 | C22H24F3N5O4 | 1402059-21-5 | Details |
PARP-2-IN-1 | C21H19F4N5O3 | 2115698-83-2 | Details |
CYT-1010 hydrochloride | C35H41ClN6O5 | 1161517-81-2 | Details |
Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
Asteltoxin | C23H30O7 | 79663-49-3 | Details |
(R)-OR-S1 | C26H34BrN3O4 | 1809336-19-3 | Details |
JAK-IN-4 | C18H22N4NaO6P | 1400877-37-3 | Details |
GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
BMS-986163 | C23H28FN2O5P | 1801151-09-6 | Details |
HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
PKR activator 2 | C18H16N8OS | 2283422-04-6 | Details |
Py-MPB-amino-C3-PBD | C41H44N8O6 | 2412924-07-1 | Details |
Isoxsuprine-monoester-1 | C23H31NO4 | 67160-74-1 | Details |
JMV 2959 hydrochloride (925238-89-7 free base) | 2448414-54-6 | Details |
Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
13-Hydroxystevane | C20H34O | 5749-44-0 | Details |
GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
TP-004 | C17H16F3N5O | 1454299-21-8 | Details |
DC-5163 | C18H20ClN3OS | 897771-47-0 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
OSMI-2 | C26H25N3O7S2 | 2260542-60-5 | Details |
RIP2 kinase inhibitor 1 | C17H17N5O2S | 2380028-10-2 | Details |
VBIT-3 | C21H19ClF3N3O3 | 2088463-66-3 | Details |
TT-232 TFA(147159-51-1 free base) | 2703745-48-4 | Details |
A2B57 | C22H19N5O | 1602733-73-2 | Details |
Chitinase-IN-2 hydrochloride | C20H22ClN5O2S | 2070014-83-2 | Details |
Tecovirimat hydrate | C19H17F3N2O4 | 1162664-19-8 | Details |
Bocconoline | C22H21NO5 | 1322007-90-8 | Details |
(+/-)-Terreic acid | C7H6O4 | 15255-24-0 | Details |
(Rac)-PF-06250112 | C22H20F2N6O2 | 1609465-88-4 | Details |
(S)-Gyramide A | C21H27FN2O3S | 1000592-48-2 | Details |
CD235 | C26H20FN5O2 | 1627716-57-7 | Details |
Isoproterenol bitartrate | C11H17NO3.C4H6O6 | 59-60-9 | Details |
PPTN | C29H24F3NO2 | 1160271-30-6 | Details |
ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
Product Total: Product Page: | ||||
138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 |